Hillstream BioPharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Hillstream BioPharma generated cash of -$7,300,106, which is less than the previous year. Cash used in financing activities reached the amount of $11,724,924 last year. Net change in cash is therefore $4,424,818.
Cash Flow
| 2019 | -706.11K | 0 | 708.38K |
|---|---|---|---|
| 2020 | -1.07M | 0 | 1.23M |
| 2021 | -1.08M | 0 | 898.74K |
| 2022 | -6.55M | 0 | 13.06M |
| 2023 | -7.30M | 0 | 11.72M |
HILS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 6.51M | 4.35K | 191.85K | 38.28K | 36.00K |
Operating activities | |||||
Net income | -9.31M | -8.47M | -2.20M | -2.41M | -1.52M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 1.56B | 666.56K | 0 | 0 |
Stock-based compensation expense | 831.86K | 800.69K | 1.23M | 234.58K | 92.01K |
| Deferred income tax benefit | 831.86K | 800.69K | 1.23M | 234.58K | 92.01K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -45.92K | -141.17K | 850.29K | 306.57K | -30.42K |
Cash generated by operating activities | -7.30M | -6.55M | -1.08M | -1.07M | -706.11K |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 12.23M | 13.64M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -69.96K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 11.72M | 13.06M | 898.74K | 1.23M | 708.38K |
Net Change In Cash | 4.42M | 6.50M | -187.49K | 153.57K | 2.27K |
Cash at end of period | 10.93M | 6.51M | 4.35K | 191.85K | 38.28K |
| Data source | Data source | Data source |